Stock listing

OTC:PXMD PaxMedica, Inc. Stock

Home listing (OTC) of PaxMedica, Inc.

Follow PaxMedica, Inc. into a list and get an email when it puts out news.

Share price · OTC:PXMD

$0.0005 USD 0.0000 (0.0%)

Close on Nov 18, 2026

Past year +400.0% · daily closes, Nov 18, 2025 – Nov 18, 2026, adjusted for splits
Day range
$0.0005 – $0.0005 USDNov 18, 2026
Volume
20,701 sharesNov 18, 2026
Market cap
$63,132 USDAt the close on Nov 18, 2026 · price × 126.3M shares outstanding
52-week range
$0.0001 – $0.0200 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
Traded on an average day
$1 USDMedian day 0 shares · 42 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026
PaxMedica, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:PXMD · Home$0.0005 USD0.0000 (0.0%)20,701$0.0005$0.0005$0.0005$0.0005Close on Nov 18, 2026

Daily closes

Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:PXMD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00050.00000.0%$0.0005$0.0005$0.000520,701
$0.00050.00000.0%$0.0005$0.0005$0.00055,100
$0.0005-0.0002-28.6%$0.0005$0.0005$0.0005759
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0005$0.0007$0.0005569
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0005$0.0007$0.000520,965
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.0007+0.0002+40.0%$0.0007$0.0007$0.00073,500
$0.00050.00000.0%$0.0005$0.0005$0.00051,577
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.0005-0.0002-28.6%$0.0005$0.0005$0.0005257
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.0007+0.0002+40.0%$0.0007$0.0007$0.0007180
$0.0005-0.0002-28.6%$0.0005$0.0005$0.0005117
$0.0007+0.0002+40.0%$0.0007$0.0007$0.0007451
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.0005147
$0.0005-0.0002-28.6%$0.0005$0.0005$0.0005400
$0.0007+0.0002+40.0%$0.0007$0.0007$0.0007112
$0.00050.00000.0%$0.0005$0.0005$0.0005299
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00051,004
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.0005-0.0002-28.6%$0.0005$0.0005$0.0005139
$0.0007+0.0002+40.0%$0.0007$0.0007$0.0007246
$0.0005-0.0002-28.6%$0.0005$0.0005$0.00051,788
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.0007106
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.0007+0.0002+40.0%$0.0007$0.0007$0.00073,000
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.0005-0.0003-37.5%$0.0005$0.0005$0.000535,820
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.0008+0.0001+14.3%$0.0008$0.0008$0.0008207
$0.00070.00000.0%$0.0007$0.0007$0.00070
$0.0007+0.0002+40.0%$0.0007$0.0007$0.0007860

Splits

1 split · OTC:PXMD · every price before a split is adjusted for it

DayRatioWhat
1-for-17Consolidation
Ticker
OTC:PXMD
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

Kuvatris Therapeutics, Inc. SEC 10-Q Report

Jan 14, 2026

Closed $0.0001 (0.0%) on Jan 15, 2026

All PaxMedica, Inc. news

PaxMedica, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 1 in all · newest Jan 14, 2026 · oldest 2026
Decks
4 decks · latest Mar 13, 2024

Where PaxMedica, Inc. is listed

ListingExchangeCountryCurrency
OTC:PXMD · Home listing · This pageOTCUnited StatesUSD
BIVA:PXMDBIVAMexicoMXN
BMV:PXMDBMVMexicoMXN

Valuation

price Nov 18, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.10

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PaxMedica, Inc. · OTC:PXMDUS$63,132n/an/an/an/an/an/an/a0.10
Vaxil Bio Ltd. · TSXV:VXLUS$319,500−US$4,0701.2×n/an/a0.4×n/a0.0×-0.16
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
GB Sciences, Inc. · OTC:GBLXUS$81,414US$2.07Mn/an/an/an/an/an/a-0.46
Lyra Therapeutics, Inc. · OTC:LYRAUS$53,246US$14.42Mn/a36.2×n/an/an/an/a0.67
Median of the othersUS$192,289US$73,5101.2×18.5×0.2×−382.1%0.0×1.14

Events

QuarterResults
Q3 2024Nov 29, 2024
Q2 2024Sep 20, 2024
Q1 2024May 13, 2024 · After close
Q4 2023Mar 11, 2024 · After close
Q3 2023Nov 16, 2023 · After close
Q2 2023Aug 30, 2023
Q4 2022Mar 30, 2023
Q3 2022Nov 14, 2022
Q2 2022Aug 29, 2022
Q4 2021Jan 4, 2022

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (March 2024)Investor deck17 slidesMar 13, 2024
Investor Presentation (December 2022)Investor deck24 slidesDec 19, 2022
Investor Presentation (October 2022)Investor deck24 slidesOct 12, 2022
IPO Roadshow (August 2020)IPO roadshow29 slidesAug 28, 2020

Open Decks

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018
Revenue00000
Research and development3.92M1.79M2.23M936.8K484.1K
Selling, general and administrative12.2B8.82M4.97M4.63M114.5K
Operating income-16.1M-10.6M-7.20M-5.57M-598.6K
Depreciation and amortization2.13M5.90M173.4K53.5K171.9K
EBITDA-14.0M-4.70M-7.02M-5.51M-426.7K
Interest expense9.16K5.24K2.81M609.5K00
Income before tax-18.3M-14.8M-10.2M-7.83M-598.6K
Income tax-167.9K4.19M2.81M663.0K-171.9K
Net income-18.3M-14.8M-13.0M-8.49M-598.6K
Earnings per share, basic-11.00-28.79-18.81-14.41-1.02

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents4.71M1.90M444.1K1.12M24.9K9.32K
Receivables00
Current assets5.68M2.20M444.1K1.12M24.9K9.32K
Total assets5.68M2.20M648.9K1.12M24.9K9.32K
Accounts payable830.2K722.0K736.3K346.1K41.0K2.45K
Current liabilities1.80M2.10M10.8M5.75M123.2K6.60K
Total debt173.5K611.6K
Total liabilities2.30M2.10M10.8M5.75M123.2K6.60K
Shareholders' equity3.39M108.8K-10.1M-4.63M-98.3K2.72K
Shares outstanding1.66M514.2K692.9K589.2K589.2K9.86M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-10.8M-6.07M-5.51M-2.35M-419.4K-279.9K
Capital spending000000
Free cash flow-10.8M-6.07M-5.51M-2.35M-419.4K-279.9K
Cash from investing-7.70K
Cash from financing13.6M7.53M4.83M3.45M435.0K300.0K
Dividends paid-11.9B-35.0K
Share buybacks-196.0K-35.0K
Change in cash2.81M1.46M-679.5K1.10M15.6K12.4K

Open Financials

Cap table

Built by 6ix from PaxMedica, Inc.’s releases

Common shares
126,264,370
Fully diluted
126,264,370

Fully diluted

LineShares
Common shares126,264,370

Share count over time

CountShares
Nov 22, 2026126,264,370

Open Cap table

Shareholders

StakeStakeSharesDateFiling
Lind Global Fund II LP9.90%985KDec 31, 2024Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles J. Casamento
Other companies: GT Biopharma, Inc. (Independent Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); Relmada Therapeutics, Inc. (Chairman of the Board · Since at least Oct 20, 2017); GridAI Technologies Corp. (Director · Mar 3, 2017 – Jan 2, 2024 · Past); International Stem Cell Corporation (Director · Mar 31, 2016 – Jun 21, 2018 · Past)
Director · Oct 1, 2022 – Mar 12, 2024 · Past
Zachary Rome
Other companies: Timber Pharmaceuticals Inc (Director · May 18, 2020 – Mar 4, 2022 · Past)
Director · Aug 12, 2022 – Mar 12, 2024 · Past
John F CoelhoDirector · Aug 12, 2022 – Mar 12, 2024 · Past
Karen LaRochelleDirector · Aug 12, 2022 – Mar 12, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about PaxMedica, Inc.